Thymosin Beta-4 Cardiac Protection Research | MI Study
A landmark preclinical study found thymosin beta-4 (TB-500) was cardioprotective after myocardial infarction in animal models. Learn what the research shows.
A landmark preclinical study found thymosin beta-4 (TB-500) was cardioprotective after myocardial infarction in animal models. Learn what the research shows.